A new tool to enhance the efficacy of chemoembolization to treat primary and metastatic hepatic tumors

Expert Opinion on Drug Delivery

Volumn 8, Issue 4, 2011, Pages 409-413

  Fiorentini, Giammaria ^a,b  

^a San Giuseppe Hospital   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Chemoembolization; doxorubicin; drug eluting bead; liver cancer

Indexed keywords

2 ACRYLAMIDO 2 METHYLPROPANESULFONATE SODIUM; CARMUSTINE; CISPLATIN; CYTARABINE; DIAZIQUONE; DOXORUBICIN; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; GLYCOPROTEIN P; IRINOTECAN; METHOTREXATE; MITOMYCIN; MULTIDRUG RESISTANCE PROTEIN; POLYVINYL ALCOHOL; SODIUM ION; SORAFENIB; SULFONIC ACID DERIVATIVE; THYMIDINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELUTING BEAD; DRUG EXPOSURE; HEPATIC ARTERY; HUMAN; HYPOXIA; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; PRIMARY TUMOR; RADIOFREQUENCY ABLATION; REVIEW; SUSTAINED RELEASE PREPARATION;

ANTINEOPLASTIC AGENTS; CHEMOEMBOLIZATION, THERAPEUTIC; DRUG CARRIERS; HUMANS; LIVER; LIVER CIRCULATION; LIVER NEOPLASMS; MICROSPHERES; REGIONAL BLOOD FLOW;

EID: 79952956251     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2011.565327     Document Type: Review

References (25)

1. Lewis AL, Holden RR. DC Bead embolic drug-eluting bead: Clinical application in the locoregional treatment of tumours. Expert Opin Drug Deliv 2011;2:153-69
2. Lien WM, Ackerman NB. The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. Surgery 1970;68:334-40
3. Ridge JA, Bading JR, Gelbard AS, et al. Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer 1987;59:1547-53 (Pubitemid 17060093)
4. Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984;2:498-504. Pharmacological formula for regional drug delivery. (Pubitemid 14075984)
5. Sigurdson ER, Ridge JA, Kemeny N, et al. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 1987;5:1836-40 (Pubitemid 18020851)
6. Ensminger WD, Gyves JW. Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 1983;10:176-82 (Pubitemid 13050371)
7. Borner M, Castiglione M, Triller J, et al. Considerable side effects of chemoembolization for colorectal carcinoma metastatic to the liver. Ann Oncol 1992;3:113-15
8. Berger DH, Carrasco CH, Hohn DC, et al. Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: Post-treatment management and complications. J Surg Oncol 1995;60:116-21
9. Mavligit GM, Charnsangavej C, Carrasco CH, et al. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA 1988;260:974-6
10. Nicolini A, Martinetti L, Crespi S, et al. Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma. J Vasc Interv Radiol 2010;21(3):327-32
11. Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION V study. Cardiovasc Intervent Radiol 2010;33(1):41-52. First prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma.
12. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58 (Pubitemid 37328807)
13. Krishna R, Mayer LD. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 2000;11:265-83
14. Pelletier G, Roche A, Ink O, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990;11:181-4
15. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 2002;359:1734-9. First randomized controlled trial of TACE versus symptomatic treatment in patients with unresectable hepatocellular carcinoma. (Pubitemid 34607087)
16. Venook AP. Embolization and chemoembolization therapy for neuroendocrine tumors. Curr Opin Oncol 1999;11:38-41 (Pubitemid 29082054)
17. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112-18
18. Lang EK, Brown CL Jr. Colorectal metastases to the liver: Selective chemoembolization. Radiology 1993;189:417-22 (Pubitemid 23321421)
19. Martinelli DJ, Wadler S, Bakal CW, et al. Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma. Cancer 1994;74:1706-12 (Pubitemid 24301823)
20. Hunt TM, Flowerdew AD, Birch SJ, et al. Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg 1990;77:779-82 (Pubitemid 20236119)
21. Hartnell GG. Effectiveness and complications of treating neuroendocrine metastases, embolization versus chemoembolization. J Vasc Interv Radiol 1999;10:1416-17
22. Kerr DJ. Microparticulate drug delivery system as an adjuct to cancer treatment. Cancer Drug Deliv 1987;5:55-61 (Pubitemid 18038599)
23. Varela M, Real MI, Burrel M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics. J Hepatol 2007;46(3):474-81 (Pubitemid 46201723)
24. Fiorentini G, Aliberti C, Montagnani F, et al. Trans-Arterial Chemoembolization of metastatic Colorectal Carcinoma (MCRC) to the liver adopting Polyvinyl Alcohol Microspheres (PAM) loaded with Irinotecan compared with FOLFIRI (CT): Evaluation at two years of a phase III clinical trial. Proceeding ESMO 2010, Abstract 588PD First randomized trial of trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting polyvinyl alcohol microspheres (PAM) loaded with irinotecan compared with FOLFIRI (CT).
25. Fiorentini G, Aliberti C, Del Conte A, et al. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study. In Vivo 2009;23(1):131-7